Cameco Corp (CCJ) concluded trading on Wednesday at a closing price of $79.15, with 4.9 million shares of worth about $388.19 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 47.78% during that period and on July 23, 2025 the price saw a gain of about 1.60%. Currently the company’s common shares owned by public are about 435.32M shares, out of which, 433.82M shares are available for trading.
Stock saw a price change of 3.89% in past 5 days and over the past one month there was a price change of 13.53%. Year-to-date (YTD), CCJ shares are showing a performance of 69.74% which increased to 54.02% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $35.00 but also hit the highest price of $80.05 during that period. The average intraday trading volume for Cameco Corp shares is 5.45 million. The stock is currently trading 6.21% above its 20-day simple moving average (SMA20), while that difference is up 19.84% for SMA50 and it goes to 47.69% higher than SMA200.
Cameco Corp (NYSE: CCJ) currently have 435.32M outstanding shares and institutions hold larger chunk of about 76.13% of that.
The stock has a current market capitalization of $34.46B and its 3Y-monthly beta is at 1.05. PE ratio of stock for trailing 12 months is 194.42, while it has posted earnings per share of $0.41 in the same period. Its PEG reads 3.44 and has Quick Ratio of 1.26 while making debt-to-equity ratio of 0.15. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CCJ, volatility over the week remained 3.74% while standing at 3.74% over the month.
Stock’s fiscal year EPS is expected to rise by 118.94% while it is estimated to increase by 51.95% in next year. EPS is likely to grow at an annualized rate of 56.55% for next 5-years, compared to annual growth of 15.41% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on May 20, 2025 offering a Buy rating for the stock and assigned a target price of $65 to it. Stock get an Overweight rating from Cantor Fitzgerald on July 31, 2024.
